Our country bears a heavy burden of benign prostatic hyperplasia (BPH). Optimizing drug treatment strategies, particularly strengthening the comprehensive management of BPH patients before, during, and after surgery, has become a focus of attention in the field of urology.
As one of the main types of medications for BPH treatment, 5α-reductase inhibitors, especially finasteride (Proscar®), have brought significant benefits to global BPH patients in reducing prostate volume and alleviating lower urinary tract symptoms (LUTS) over the past 30 years since its market introduction, thanks to its outstanding efficacy and safety. Based on extensive evidence from evidence-based medicine and rich clinical practice experience, finasteride has also shown to play an increasingly critical role in the perioperative management of BPH, providing strong support for enhancing surgical outcomes and promoting postoperative recovery.
In this interview, CCMTV invites Professor Wu Wenqi from the Second Affiliated Hospital of Guangzhou Medical University to conduct an in-depth summary and sharing of the latest advances in surgical techniques for BPH and strategies for optimizing drug management, with the aim of enhancing everyone’s clinical diagnosis and treatment capabilities, further improving the treatment effectiveness of BPH and the quality of life for patients.
CCMTV
Drug treatment has gradually become the first-line treatment for BPH. The first selective 5α-reductase inhibitor, finasteride, has had its long-term efficacy confirmed over the past 30 years. However, for some patients, surgical treatment is ultimately required to relieve obstruction. As an authoritative expert in the surgical field, could you briefly outline the evolution and significant advancements in surgical treatment for BPH from a surgical perspective and practical experience?
Professor Wu Wenqi
In the treatment field of prostatic hyperplasia, in addition to initial drug therapy, surgical treatment is also a primary method. Early surgical treatments mostly employed open surgery, but due to the special location of the prostate, the exposure of the surgical field is limited, making the operation relatively complex and with a higher risk of postoperative bleeding. With
